Diabetes Unit, Massachusetts General Hospital, Boston, MA
Harvard Medical School, Boston, MA.
Diabetes. 2020 Oct;69(10):2064-2074. doi: 10.2337/dbi20-0004. Epub 2020 Aug 25.
Attention to precision medicine in type 2 diabetes (T2D) has provided two favored approaches to subclassifying affected individuals and parsing heterogeneity apparent in this condition: phenotype-based and genotype-based. Gestational diabetes mellitus (GDM) shares phenotypic characteristics with T2D. However, unlike T2D, GDM emerges in the setting of profound pregnancy-related physiologic changes in glucose metabolism. T2D and GDM also share common genetic architecture, but there are likely to be unique genetic influences on pregnancy glycemic regulation that contribute to GDM. In this Perspective, we describe efforts to decipher heterogeneity in T2D and detail how we and others are applying approaches developed for T2D to the study of heterogeneity in GDM. Emerging results reveal the potential of phenotype- and genotype-based subclassification of GDM to deliver the promise of precision medicine to the obstetric population.
关注 2 型糖尿病(T2D)的精准医学为分类受影响个体和解析该疾病中明显的异质性提供了两种有利方法:基于表型和基于基因型。妊娠糖尿病(GDM)与 T2D 具有表型特征。然而,与 T2D 不同的是,GDM 出现在葡萄糖代谢方面发生深刻妊娠相关生理变化的环境中。T2D 和 GDM 也具有共同的遗传结构,但可能存在对妊娠血糖调节有独特遗传影响的因素,这有助于 GDM 的发生。在本观点中,我们描述了破解 T2D 异质性的努力,并详细介绍了我们和其他人如何将针对 T2D 开发的方法应用于 GDM 异质性的研究。新兴的结果表明,基于表型和基因型的 GDM 分类有潜力将精准医学的承诺带给产科人群。